Buscar
Assertio Holdings Inc
ASRTAñadir a la lista de seguimiento
23.495USD
0.0000.00%
Cierre 07/02, 13:00（ET）Cotizaciones retrasadas 15 min
151.86MCap. mercado
PérdidaP/E TTM
Más Datos de Assertio Holdings Inc Compañía
Assertio Holdings, Inc. is a pharmaceutical company offering differentiated products to patients. The Company has built its commercial portfolio through the acquisition or licensing of approved products. Its commercial capabilities include marketing through both a sales force and an omni-channel promotion model, market access through payor contracting, and trade and distribution. The Company’s primary marketed products include ROLVEDONTM (eflapegrastim-xnst) injection for subcutaneous use, INDOCIN (indomethacin) Suppositories, INDOCIN (indomethacin) Oral Suspension, Sympazan (clobazam) oral film, Otrexup (methotrexate) injection for subcutaneous use, SPRIX (ketorolac tromethamine) Nasal Spray, and CAMBIA (diclofenac potassium for oral solution). INDOCIN (indomethacin) Suppositories and INDOCIN (indomethacin) Oral Suspension products are nonsteroidal anti-inflammatory drugs (NSAID). Otrexup is a once weekly single-dose auto-injector containing methotrexate.
Información de Assertio Holdings Inc
Símbolo de cotizaciónASRT
Nombre de la empresaAssertio Holdings Inc
Fecha de salida a bolsaFeb 12, 1997
Director ejecutivoReisenauer (Mark L)
Número de empleados58
Tipo de seguridadOrdinary Share
Fin del año fiscalFeb 12
Dirección100 S. Saunders Road
CiudadLAKE FOREST
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal60045
Teléfono12244197106
Sitio Webhttps://www.assertiotx.com/
Símbolo de cotizaciónASRT
Fecha de salida a bolsaFeb 12, 1997
Director ejecutivoReisenauer (Mark L)
Ejecutivos de Assertio Holdings Inc
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Sam Schlessinger
Mr. Sam Schlessinger
Executive Vice President, General Counsel
Executive Vice President, General Counsel
13.35K
+22.04%
Mr. David Matthew Stark
Mr. David Matthew Stark
Independent Director
Independent Director
9.03K
+53.71%
Mr. Mark L. Reisenauer
Mr. Mark L. Reisenauer
Chief Executive Officer, Director
Chief Executive Officer, Director
1.20K
--
Ms. Heather L. Mason
Ms. Heather L. Mason
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. William T. Mckee
Mr. William T. Mckee
Independent Director
Independent Director
--
--
Mr. Paul Schwichtenberg
Mr. Paul Schwichtenberg
President, Chief Operating Officer
President, Chief Operating Officer
--
-100.00%
Mr. Ajay Patel
Mr. Ajay Patel
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
--
-100.00%
Mr. Sravan K. Emany
Mr. Sravan K. Emany
Independent Director
Independent Director
--
--
Mr. Sigurd C. (Sig) Kirk
Mr. Sigurd C. (Sig) Kirk
Independent Director
Independent Director
--
--
Ms. Mary E Pietryga
Ms. Mary E Pietryga
Executive Vice President, Chief Commercial Officer
Executive Vice President, Chief Commercial Officer
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Sam Schlessinger
Mr. Sam Schlessinger
Executive Vice President, General Counsel
Executive Vice President, General Counsel
13.35K
+22.04%
Mr. David Matthew Stark
Mr. David Matthew Stark
Independent Director
Independent Director
9.03K
+53.71%
Mr. Mark L. Reisenauer
Mr. Mark L. Reisenauer
Chief Executive Officer, Director
Chief Executive Officer, Director
1.20K
--
Ms. Heather L. Mason
Ms. Heather L. Mason
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. William T. Mckee
Mr. William T. Mckee
Independent Director
Independent Director
--
--
Mr. Paul Schwichtenberg
Mr. Paul Schwichtenberg
President, Chief Operating Officer
President, Chief Operating Officer
--
-100.00%
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Assertio Holdings Inc?
Los cinco principales accionistas de Assertio Holdings Inc son: Mr. Sam Schlessinger
¿Cuántas instituciones poseen acciones de Assertio Holdings Inc (ASRT)?
A fecha de 2026Q1, 213 instituciones poseen acciones de Assertio Holdings Inc, con un valor de mercado combinado de aproximadamente 2.20M, lo que representa el 34.20% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -70665.00.
¿Cuál es la mayor fuente de ganancias de Assertio Holdings Inc?
El 2026Q1, el segmento empresarial ROLVEDON generó la ganancia más alta para Assertio Holdings Inc, ascendiendo a 68.22M y representando el 57.47% de la ganancia total.